Combination Versus Alone Liposomal Bupivacaine Blocks in Minimally Invasive Thoracic Surgery-1

Combination Versus Alone Liposomal Bupivacaine Blocks in Minimally Invasive Thoracic Surgery-1
Conditions: Lung Cancer (Diagnosis)

Interventions: Procedure: Arm 1 “LipoB-I”: Liposomal Bupivacaine via Multi-Level Intercostal Nerve Block; Procedure: Arm 2 “LipoB-S”: Liposomal Bupivacaine via Serratus Anterior Plane Block; Procedure: Arm 3 “LipoB-C”: Liposomal Bupivacaine Administered via Combination Block

Sponsors: University of Texas Southwestern Medical Center; The University of Texas at Dallas; Simmons Cancer Center

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 30, 2025Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments